# Jinko Holdings Ltd: Form 20-F for the period ended Dec 31, 2025

- Company: [Jinko Holdings Ltd](/companies/jks.md) (CIK 1481513)
- Form: 20-F
- Filed: 2026-04-29
- Accepted by EDGAR: Apr 29, 2026, 06:20 ET
- Period: 2025-12-31
- Accession: 0001104659-26-050737
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1481513/000110465926050737/jks-20251231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1481513/000110465926050737/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $9.37bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $9.16bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $201.7m | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $128.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | −$1.27bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2025-01-01 to 2025-12-31 | $194.5m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | −$317.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$635.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | −$3.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | −$3.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 208,412,077 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $154.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $455.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2025-12-31 | $2.86bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $9.84bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $17.31bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $7.87bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $13.36bn | us-gaap:Liabilities |
| Current portion of debt | at 2025-12-31 | CNY 10.66bn | us-gaap:DebtCurrent |
| Short-term borrowings | at 2025-12-31 | CNY 10.66bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-12-31 | $2.25bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2025-12-31 | 209,429,353 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1481513/000110465926050737/jks-20251231x20f.htm

Filed Apr 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-050737. Last ingested by Listed: Oct 30, 2026, 08:50 ET. No prices; not investment advice.